Sartorius Stedim Biotech S.A. (SRTOY)
OTCMKTS · Delayed Price · Currency is USD
22.99
0.00 (0.00%)
Oct 6, 2025, 8:00 PM EDT
Sartorius Stedim Biotech Revenue
Sartorius Stedim Biotech had revenue of 745.00M EUR in the quarter ending June 30, 2025, with 5.46% growth. This brings the company's revenue in the last twelve months to 2.90B, up 5.44% year-over-year. In the year 2024, Sartorius Stedim Biotech had annual revenue of 2.78B with 0.16% growth.
Revenue (ttm)
2.90B EUR
Revenue Growth
+5.44%
P/S Ratio
6.58
Revenue / Employee
292.54K EUR
Employees
9,901
Market Cap
22.37B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.78B | 4.50M | 0.16% |
| Dec 31, 2023 | 2.78B | -717.20M | -20.53% |
| Dec 31, 2022 | 3.49B | 605.70M | 20.98% |
| Dec 31, 2021 | 2.89B | 976.92M | 51.15% |
| Dec 31, 2020 | 1.91B | 469.51M | 32.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Elite Pharmaceuticals | 105.45M |
| Glass House Brands | 221.55M |
| Veradigm | 588.02M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Jushi Holdings | 256.36M |
| Nuo Therapeutics | 1.95M |
Sartorius Stedim Biotech News
- 2 months ago - Sartorius Stedim Biotech and Nanotein Technologies Partner to Advance Cell Therapy Manufacturing - Business Wire
- 2 months ago - Bio Usawa Biotechnology and Sartorius Stedim Biotech Forge Partnership to Pioneer Biopharmaceutical Manufacturing in Africa - GlobeNewsWire
- 3 months ago - Sartorius Stedim Biotech and Sensible Biotechnologies Partner to Scale Up Sensible's Unique Cell-Based mRNA Design and Manufacturing Platform - Business Wire
- 8 months ago - Sartorius Stedim Biotech SA (SDMHF) Q4 2024 Earnings Call Highlights: Navigating Growth Amid ... - GuruFocus
- 9 months ago - Sartorius, Sartorius Stedim Biotech shares jump after results beat - Reuters
- 1 year ago - Sartorius Stedim Biotech S.A. (SDMHF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Sartorius Stedim Biotech S.A. reports Q3 results - Seeking Alpha
- 1 year ago - Sartorius Stedim Biotech S.A. (SDMHF) H1 2024 Earnings Call Transcript - Seeking Alpha